Advisors

David Feldman is a lawyer, advisor and entrepreneur still deciding what to do when he grows up. He has been a leading out-of-the-box guide to hundreds of growing businesses in his over 30 years of experience. He’s the author of four books on finance and entrepreneurship, and is known as one of the leading cannabis finance attorneys in the U.S., having served most recently as Co-Lead of the 60-lawyer Cannabis Practice Group for an AmLaw 100 law firm. In April 2019 the global guide Chambers & Partners ranked David as a leading US attorney in cannabis law and one of only seven US lawyers in “band 1” for corporate and transactional work in the industry. In addition, in October 2018 the National Law Journal named him a “Cannabis Law Trailblazer” and in January 2019 Business Insider named him as a top lawyer in the cannabis industry. Recent win: he conceived financing innovations such as the SEC’s Regulation A+, a simplified and streamlined approach for going public in the US and Canada.

A Wharton graduate and former Chair of the school’s worldwide alumni, David is not just a lawyer – he’s a community builder. He’s run, built, bought, invested in, and sold businesses. He feels his clients’ pain but provides the objective outsider’s point of view that founders need. He’s our “Velvet Hammer”: a calm, clear, and firm guide and mentor, who is both practical and honest. His ‘no jerks’ policy in accepting clients, partners, and employees keeps morale, energy, and results ‘high on the list’ in Skip Intro Advisors company culture.

Siki Giunta is a seasoned executive with comprehensive knowledge of software, cloud, blockchain and analytics. She has led international operations and distribution with specialization in technology due diligence and acquisition.

She has led development teams, served as CEO of multiple companies, raised funding and consulted to businesses worldwide who are modernizing and growing. Her successes include developing and bringing to market revenue-generating solutions and providing advisory services to emerging and modern technology companies across sectors. Her passion is innovation and her magic comes from a deep understanding of what customers want to buy.

Jeanne Sullivan is passionate about delivering ideas – connections – and inspiration and is a fierce advocate for legalization and regulation of the Cannabis industry. Jeanne is a co-founder of a venture capital firm in NYC and held operating roles at AT&T and Bell Labs as part of an entrepreneurial team. Sullivan is a proud member of the Arcview team and is building investment platforms under the Arcview banner.

Jeanne served for several years as a member of the Women’s Leadership Board at the Harvard Kennedy School and is an Athena Entrepreneur Fellow for Barnard College. She is on the Global Board of Trustees of Astia, funding high-growth women entrepreneurs. Jeanne also serves on the Board of Trustees of the New York Hall of Science. Business Insider named Sullivan one of the “rising stars” in the cannabis industry.

Ron has unyielding passion for actionable research focused on cultivating relationships and opportunities. His background is steeped in corporate strategy and market research, where he brings a sense of unquenchable curiosity. For Ron, nothing releases more dopamine than digging deep and connecting unique, value-added and disparate concepts, professionals and organizations. Ron is enthralled by countless opportunities for new markets, innovations, and partnerships in cannabis, arguably the world’s fastest growing CPG industry.

Ron also brings a bird’s eye view to the team as Director of Strategic Partnerships at Vertosa, focusing on cannabinoid-infused food and beverage (a critical area for the ongoing evolution of the industry). Additionally, Ron has often been tasked with meeting the complex needs of top management – including as Chief of Staff to the President of UBS PaineWebber among other positions. He was also a trusted advisor to the Chairman of Centurion Holdings (family office/consulting firm). His efforts there were critical to exploiting new markets that transformed a key portfolio company from a failing business to a key player in its industry, resulting in a recent sale for $170 Million. He also gained invaluable experience at BofA Merrill Lynch, Long Term Capital Management and Coopers & Lybrand.

Born in Israel and raised in Queens, Ron is an avid New Yorker that loves his city and appreciates the immense impact it will have on the booming cannabis industry. He graduated early (cum laude) from New York University’s Undergraduate School of Business, began his career as a CPA, and is a CFA charter-holder.

Licensed to practice law in California and Colorado, Courtney Barnes specializes in advising clients on regulatory compliance, risk management, contract creation, and strategic operational matters as it relates to the production and distribution of hemp, cannabis, and other natural products in emerging industries. Her legal expertise includes providing bespoke DEA, FDA, and state regulatory compliance guidance, including licensing, distribution, and advertising strategy to consumer-packaged goods (CPG) manufacturers, retailers, and ancillary service providers. She specializes in complex legal analyses relating to the manufacture, marketing, and sale of a variety of stringently regulated compounds.

In addition to her legal practice, Ms. Barnes is a passionate psychedelics and criminal justice policy reform advocate who has vast experience drafting and helping to implement state and local policy change relating to the regulation of cannabis and the decriminalization of psychedelics. Most notably, she assisted with the drafting of Denver’s cannabis social use ordinance in 2016, Denver’s psilocybin decriminalization initiative in 2018; Texas’ commercial hemp program in 2019 and numerous others. She is also State Policy Advisor for Decriminalize Nature, General Counsel of the Society for Psychedelic Outreach, Reform, and Education (SPORE), and is an Advisory Board Member of Heroic Hearts Project, Inc.

Courtney received her Juris Doctor from the University of Denver Sturm College of Law and graduated Summa Cum Laude from the University of South Florida, where she earned a Bachelor of Arts in psychology and a Bachelor of Arts in mass communications with a concentration in journalism.

Jessica Steinberg is an Associate at Feldman Legal Advisors PLLC, licensed to practice law in England & Wales. She holds the first PhD on regulated cannabis from the University of Oxford, where her ethnographic legal research spanned eleven countries and examined global legal reform and market development. Since 2018, Jessica has consulted public and private entities, investors, and governmental bodies on regulatory compliance matters across emerging therapies and technologies. Her work has led to a UN delegacy at the Commission on Narcotic Drugs and the WHO, and in 2025 she was short-listed as “Industry Rising Star” for her contributions to the cannabis sector. She also supported the cannabis desk at Dentons US, assisting large multi-state operators.

Jessica’s academic and professional background has equipped her with expertise in due diligence, fact-finding, deposition preparation, negotiation, and transactional support. She counsels clients on commercial agreements, corporate governance, and licensing, as well as packaging, labeling, and regulatory compliance. Her approach combines rigorous analysis with strategic insight, helping clients navigate complex and evolving regulatory landscapes.

In addition to her legal practice, Jessica provides pro bono support to the Digital Intimacy Coalition, a European initiative focused on privacy, consent, and ethical innovation in technologies related to intimacy and personal data. Her leadership and commentary have been featured by BBC Radio 4, Benzinga, the New York Times, Forbes, Reuters, and Vice. A seasoned public speaker for over 13 years, she has appeared as a keynote speaker, panelist, moderator, and podcast guest.